Inventor
DHANARAJ SRIDEVI
US29 patents
⚠️ This page may combine multiple inventors who share the name “DHANARAJ SRIDEVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ETHICON INC
8 patentsUS7749204B2Jul 6, 2010
Reinforced absorbable multilayered fabric for use in tissue repair and regeneration
ETHICON INC1,403 citations97
US7163920B2Jan 16, 2007
Peptide with osteogenic activity
ETHICON INC23 citations88
US10265091B2Apr 23, 2019
Surgical stapler/cutter and extended buttress
ETHICON INC11 citations84
US12576183B2Mar 17, 2026
Methods and devices for changing the flow rates of pH modifying fluids for controlling cross-linking rates of reactive components of biocompatible sealing compositions
ETHICON INC0 citations58
US11826028B2Nov 28, 2023
Two component sealing systems including synthetic matrices and biosynthetic adhesives for sealing resected surfaces of organs to control bleeding, fluid leaks and air leaks
ETHICON INC0 citations56
US12539374B2Feb 3, 2026
Systems, devices and methods for dispensing biocompatible reactive formulations and controlling cross-linking of the reactive components of the biocompatible reactive formulations
ETHICON INC0 citations50
US9801910B2Oct 31, 2017
Decellularized pleural matrix
ETHICON INC0 citations46
US10625032B2Apr 21, 2020
Spray tips for simultaneous multi-directional delivery of dissimilar fluids
ETHICON INC0 citations40
OMRIX BIOPHARMACEUTICALS LTD
6 patentsUS11007301B2May 18, 2021
Hemostatic mixture of cellulose-based short and long fibers
OMRIX BIOPHARMACEUTICALS LTD3 citations82
US10137220B2Nov 27, 2018
Hemostatic composition
OMRIX BIOPHARMACEUTICALS LTD7 citations82
US10137221B2Nov 27, 2018
Hemostatic mixture of cellulose-based short and long fibers
OMRIX BIOPHARMACEUTICALS LTD9 citations82
US11007300B2May 18, 2021
Hemostatic composition
OMRIX BIOPHARMACEUTICALS LTD2 citations71
US11712495B2Aug 1, 2023
Hemostatic mixture of cellulose-based short and long fibers
OMRIX BIOPHARMACEUTICALS LTD0 citations61
US10960105B2Mar 30, 2021
Hemostatic composition
OMRIX BIOPHARMACEUTICALS LTD0 citations61